Mark Allen

2.6k total citations
46 papers, 1.8k citations indexed

About

Mark Allen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Allen has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Mark Allen's work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Mark Allen is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Mark Allen collaborates with scholars based in United Kingdom, United States and France. Mark Allen's co-authors include David J. Tozer, Thomas J. Borody, Johnson L. Thistle, David Cunningham, Mark Hill, Nicholas F. LaRusso, Thomas F. Bugliosi, Gerald R. May, E. S. Horning and C E Dukes and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Chemical Physics.

In The Last Decade

Mark Allen

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Allen United Kingdom	19	540	484	441	237	181	46	1.8k
Richard J. Jones United States	30	821 1.5×	617 1.3×	283 0.6×	130 0.5×	306 1.7×	116	4.1k
Sik Lee South Korea	35	370 0.7×	505 1.0×	317 0.7×	582 2.5×	112 0.6×	124	4.1k
Yoshito Takeuchi Japan	28	298 0.6×	455 0.9×	462 1.0×	161 0.7×	1.1k 6.1×	243	3.1k
Yoshiyuki Kawashima Japan	30	132 0.2×	526 1.1×	662 1.5×	931 3.9×	240 1.3×	192	3.4k
Michael Lock Canada	34	669 1.2×	551 1.1×	1.8k 4.1×	303 1.3×	32 0.2×	185	3.9k
Jing Guo Germany	36	149 0.3×	256 0.5×	196 0.4×	138 0.6×	175 1.0×	117	3.4k
Hiroaki Takeda Japan	19	258 0.5×	236 0.5×	179 0.4×	164 0.7×	127 0.7×	53	1.5k
Daniel Warren United States	32	276 0.5×	1.9k 3.8×	311 0.7×	81 0.3×	118 0.7×	79	4.3k
Gerald Carlson United States	32	293 0.5×	441 0.9×	234 0.5×	330 1.4×	495 2.7×	96	2.8k
Ichiro Yamaguchi Japan	25	111 0.2×	205 0.4×	314 0.7×	554 2.3×	201 1.1×	205	2.8k

Countries citing papers authored by Mark Allen

Since Specialization

Citations

This map shows the geographic impact of Mark Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Allen more than expected).

Fields of papers citing papers by Mark Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Allen. The network helps show where Mark Allen may publish in the future.

Co-authorship network of co-authors of Mark Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Allen. A scholar is included among the top collaborators of Mark Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Allen. Mark Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Huafu, Linxiang Lan, Hengxing Chen, et al.. (2025). SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Nature. 648(8092). 203–209. 1 indexed citations

Shepherd, Scott T.C., Kabir Mohammed, Karla A. Lee, et al.. (2022). Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Breast Cancer Research and Treatment. 195(3). 333–340. 5 indexed citations

Battisti, Nicolò Matteo Luca, María Sol Andrés, Karla A. Lee, et al.. (2021). Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer. Breast Cancer Research and Treatment. 188(1). 149–163. 45 indexed citations

Battisti, Nicolò Matteo Luca, Karla Lee, Scott T.C. Shepherd, et al.. (2020). Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience. Cancer Treatment and Research Communications. 24. 100188–100188. 16 indexed citations

Battisti, Nicolò Matteo Luca, et al.. (2018). Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience. The Breast. 40. 60–66. 5 indexed citations

Battisti, Nicolò Matteo Luca, et al.. (2017). Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience. Annals of Oncology. 28. v88–v88. 1 indexed citations

Waddell, Thomas K., Anastasia Constantinidou, Nadia Yousaf, et al.. (2011). Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience. British Journal of Cancer. 104(11). 1675–1679. 20 indexed citations

Brunetto, André T., Debashis Sarker, Dionysis Papadatos-Pastos, et al.. (2010). A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. British Journal of Cancer. 103(5). 607–612. 8 indexed citations

Clarkston, Wendell, et al.. (2009). Jejunoileal bypass: A surgery of the past and a review of its complications. World Journal of Gastroenterology. 15(18). 2277–2277. 33 indexed citations

10.

Hughes, Sarah, Yolanda Barbáchano, S. Ashley, et al.. (2008). Time Trends in the Outcome of Elderly Patients with Breast Cancer. The Breast Journal. 14(2). 158–163. 8 indexed citations

11.

Allen, Mark, et al.. (2004). The observation of a large gauche preference when 2-fluoroethylamine and 2-fluoroethanol become protonated. Organic & Biomolecular Chemistry. 2(5). 732–732. 99 indexed citations

12.

Hess, Viviane, et al.. (2003). Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma. Annals of Oncology. 14(4). 638–642. 6 indexed citations

13.

Kelleher, Muireann, Niall C. Tebbutt, David Cunningham, et al.. (2003). Mitomycin C, Carboplatin and Protracted Venous Infusion 5-Fluorouracil in Advanced Oesophago–gastric and Pancreatic Cancer: Results of Two Phase II Studies. Clinical Oncology. 15(3). 92–97. 2 indexed citations

14.

Chau, Ian, Mark Allen, David Cunningham, et al.. (2003). Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. British Journal of Cancer. 88(7). 1017–1024. 65 indexed citations

15.

Allen, Mark & David J. Tozer. (2003). Polarizabilities and excitation energies from the multiplicative Kohn-Sham (MKS) approach. Molecular Physics. 101(3). 421–425. 2 indexed citations

16.

Allen, Mark & David J. Tozer. (2002). Helium dimer dispersion forces and correlation potentials in density functional theory. The Journal of Chemical Physics. 117(24). 11113–11120. 134 indexed citations

17.

Cunningham, David, Pauline M. Ross, Adam Webb, et al.. (1997). Phase I dose finding study of irinotecan hydrochloride trihydrate (CPT11) with tomudex (TX.) in patients with 5-FU refractory colorectal cancer. European Journal of Cancer. 33. S172–S172. 2 indexed citations

18.

Belkin, Michael, et al.. (1991). Modification of the Thrombogenicity of a Self-Expanding Vascular Stent. Journal of Investigative Surgery. 4(3). 269–278. 15 indexed citations

19.

Stanley, M M, Shigehiro Ochi, Bernard A. Nemchausky, et al.. (1989). Peritoneovenous Shunting as Compared with Medical Treatment in Patients with Alcoholic Cirrhosis and Massive Ascites. New England Journal of Medicine. 321(24). 1632–1638. 140 indexed citations

20.

Annis, Jeffrey, David B. Finlay, Mark Allen, & M.R. Barnes. (1987). A review of cervical-spine radiographs in casualty patients. British Journal of Radiology. 60(719). 1059–1061. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact